based on the early trials and the general experience with using synthetic and polyclonal antibodies for, uh, infectious disease like this, it's pretty effective. And he should kind of, uh, you know, recover pretty quickly. I would imagine so.View on YouTube
Evidence shows that Donald Trump received an 8‑gram intravenous dose of Regeneron’s antibody cocktail (REGEN‑COV2) on October 2, 2020, in line with the setup of the prediction. (fortune.com) He was hospitalized at Walter Reed from October 2–5 and discharged back to the White House after three days. (en.wikipedia.org) By October 8 his physician stated he was “devoid of symptoms” and anticipated a “safe return to public engagements” by October 10; Trump resumed campaign events starting October 12, indicating a functional recovery within about a week to ten days of diagnosis. (en.wikipedia.org)
Longer‑term, multiple White House medical reports in 2025 describe Trump (now in his late 70s) as in “excellent” or “exceptional” health and “fully fit,” noting only chronic issues like well‑controlled high cholesterol and mild chronic venous insufficiency; they list his 2020 COVID‑19 hospitalization only as past history, with no mention of ongoing respiratory, cardiac, or neurological impairment suggestive of severe long‑term post‑COVID complications. (reuters.com) There is no credible reporting that he developed long‑COVID, chronic oxygen dependence, or other major sequelae.
Taken together, Trump (1) recovered and returned to normal public activity within roughly a week to ten days, and (2) did not die or show documented long‑term severe complications attributable to his 2020 COVID‑19 infection. That aligns closely with Friedberg’s prediction, so the forecast is best judged as right.